Work

Targeting IL-1/IRAK1/4 signaling in acute myeloid leukemia stem cells following treatment and relapse

Year: 2025

Type: article

Source: Leukemia

DOI: 10.1038/s41375-025-02816-y

Authors: Tzu-Chieh Ho, Mark W. LaMere, Hiroki Kawano, Daniel K. Byun, Elizabeth A. LaMere, Yu-Chiao Chiu, Chunmo Chen, Li-Ju Wang, Jian Wang, Baskar Ramdas, Nikolay V. Dokholyan, Laura M. Calvi, Jane L. Liesveld, Craig T. Jordan, Rakesh K. Singh, Reuben Kapur, Michael W. Becker

Institutions: University of Rochester Medicine, Indiana University Indianapolis, Indiana University School of Medicine, University of Rochester, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pennsylvania State University, University of Virginia, University of Colorado Denver

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Roswell Park Cancer Institute, Leukemia and Lymphoma Society, Leukemia Research Foundation, University of Rochester, National Institutes of Health, Medical Center, University of Rochester, School of Medicine, Indiana University, National Cancer Institute, National Institute of General Medical Sciences, National Center for Complementary and Integrative Health, Wilmot Cancer Institute, University of Rochester Medical Center

Awards: G1700758870, G1807469355, G3489661315, G4606253093, G5832144797, G8974474145, G9000126190, University of Virginia Cancer Center Support Grant

OpenAlex ID: W4417485490

FWCI: 2.567

Cites: 61

Cited by: 4

Related to: